New clinical trial registered for Glucagon

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity (NCT07497880) registered on ClinicalTrials.gov. Phase: phase 2. Status: not yet recruiting.